German chemicals giant Evonik and Guangdong Marubi Biotechnology Co., Ltd. (Marubi) of China have entered into a cooperation agreement to support the development of the Chinese cosmetics industry.
The duo said local cosmetic consumers will benefit from both companies’ complementary capabilities in raw materials, research, development and production.
In addition, the two organizations will exchange information on diverse topics including ingredient application and development, formulation, and studies on cosmetic market trends.
Founded in 2002, Marubi is a large-scale skin care company that engages in research, development, production, sales, training and service of eyecare and anti-ageing facial skin care through science and technology.
As an industry leader in China, the company combines independent innovation with open innovation, backed by extensive global technical resources, and supports a close collaboration among the industry, university, clinic, research institute and testing authority.
Dr. Chaowan Guo, Marubi’s vice general manager of R&D, said: “We are delighted and honoured to enter into this strategic cooperation with Evonik.
“We are convinced that the deeper exchange on raw materials, formulations and market trends will lead to mutual benefits, supporting our commitment to the high-quality development of the industry, as well as our goals towards a broader international expansion.”
Evonik and Marubi will jointly promote the development and continuous upgrade of China's beauty industry.
“Working closely with customers who share a similar vision is important for us, especially in China, where the cosmetics market is booming,” said Yann d’Hervé, head of the business line Care Solutions at Evonik.
“We look forward to joining hands with Marubi to create more high-performing and sustainable products and unique experiences for consumers,” he added.
